alexa

GET THE APP

Insights for the Inhibition of Cancer Progression: Revisiting Ca<sup>2+</sup> and Camp Signalling Pathways | OMICS International| Abstract
ISSN 2472-0429

Advances in Cancer Prevention
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
  • Editorial   
  • Adv Cancer Prev 2: e103,
  • DOI: 10.4172/2472-0429.1000e103

Insights for the Inhibition of Cancer Progression: Revisiting Ca2+ and Camp Signalling Pathways

Paolo Ruggero Errante, Afonso Caricati-Neto and Leandro Bueno Bergantin*
Department of Pharmacology-Federal University of São Paulo-Paulista School of Medicine, Laboratory of Autonomic and Cardiovascular Pharmacology, , São Paulo, Brazil
*Corresponding Author : Leandro Bueno Bergantin, Department of Pharmacology-Federal University of São Paulo-Paulista School of Medicine, Laboratory of Autonomic and Cardiovascular Pharmacology, Rua Pedro De Toledo, 669-Vila Clementino, São Paulo-SP, Brazil, CEP: 04039-032, Brazil, Tel: +55 11 5576-4973, Email: [email protected]

Received Date: Feb 17, 2017 / Accepted Date: Feb 21, 2017 / Published Date: Feb 28, 2017

Abstract

This editorial article gives insights for the inhibition of cancer progression. The pharmacological modulation of Ca2+/cAMP signalling interaction is also cited.

Keywords: Cancer progression; Ca2+/cAMP signalling interaction

Citation: Errante PR, Neto AC, Bergantin LB (2017) Insights for the Inhibition of Cancer Progression: Revisiting Ca2+ and Camp Signalling Pathways. Adv Cancer Prev 2: e103. Doi: 10.4172/2472-0429.1000e103

Copyright: © 2017 Errante PR, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.

Top